title: Colonic anastomotic leak: risk factors, diagnosis, and treatment.
authors.affiliation: Department of Surgery, NYU Medical Center, New York, NY 10016, USA.
authors.forename: T Peter
authors.initials: TP
authors.lastname: Kingham
authors.forename: H Leon
authors.initials: HL
authors.lastname: Pachter
mesh_terms: D000714:Anastomosis, Surgical / Q000295:instrumentation / Q000379:methods; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D003106:Colon / Q000601:surgery*; D003108:Colonic Diseases / Q000601:surgery*; D003110:Colonic Neoplasms / Q000601:surgery; D004322:Drainage / Q000009:adverse effects / Q000295:instrumentation; D006801:Humans; D007511:Ischemia / Q000209:etiology / Q000517:prevention & control; D010535:Laparoscopy; D009364:Neoplasm Recurrence, Local / Q000209:etiology / Q000517:prevention & control; D009752:Nutritional Status; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects; D012086:Reoperation; D018570:Risk Assessment; D012307:Risk Factors; D012737:Sex Factors; D013529:Surgical Wound Dehiscence / Q000175:diagnosis* / Q000517:prevention & control* / Q000628:therapy; D013997:Time Factors
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab